Matthew Cunningham, MD, FASRS

home / authors / matthew-cunningham-md-fasrs

Matthew Cunningham, MD, FASRS

Partner and Research Director

Florida Retina Institute

Orlando, FL

Articles

Clinical Trial Overview: DME

Clinical Trial Overview: DME

Matthew Cunningham, MD, FASRS

September 22nd 2023

Matthew Cunningham, MD, FASRS, provides the highlights of the YOSEMITE and RHINE trials for patients with diabetic macular edema (DME).

Read More

Latest Updated Articles

Gursimran Kochhar, MD | Credit: Allegheny Health Network

Published: October 4th 2024 | Updated: October 14th 2024

Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network

HCPLive Cardiology Month in Review: April 2024

Published: May 2nd 2024 | Updated: May 6th 2024

Cardiology Month in Review: April 2024

Hide Okuno, MS: Tube Weaning Reduces Parental Stress, Findings Guide Future Studies

Published: November 16th 2024 | Updated: December 26th 2024

Hide Okuno, MS: Tube Weaning Reduces Parental Stress, Findings Guide Future Studies

Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS

Published: November 15th 2024 | Updated: December 26th 2024

Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS

Scott Bartley, MD I Credit: LinkedIn

Published: December 16th 2024 | Updated: December 26th 2024

Brilaroxazine Shows Long-Term Efficacy in Schizophrenia in Phase 3 RECOVER

FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis

Published: December 16th 2024 | Updated: December 26th 2024

FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.